サマリー

HER2（ヒト上皮成長因子受容体2）阻害剤の世界市場 2022-2026 年
TechnavioはHER2（ヒト上皮成長因子受容体2）阻害剤市場を監視しており、2022-2026年に8.95%のCAGRで進行し、80億ドル成長する見込みであるとしています。当レポートでは、HER2（ヒト上皮成長因子受容体2）阻害剤市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、乳がんや胃がんの高い有病率、最近の承認取得、乳がんに対する意識の高まりによって牽引されています。
HER2（ヒト上皮成長因子受容体2）阻害剤市場の分析には、製品セグメントや地理的状況も含まれます。
TechnavioのHER2（ヒト上皮成長因子受容体2）阻害剤市場は、以下のようにセグメント化されています。
製品別
- 単剤療法
- 併用療法
地理的状況別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるHER2（ヒト上皮成長因子受容体2）阻害剤市場の成長を促進する主要な理由の一つとして、患者支援プログラムが挙げられています。また、乳がんの新しい診断法の導入や戦略的提携は、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。HER2（ヒト上皮成長因子受容体2）阻害剤市場に関する当レポートは、以下の分野を対象としています。
- HER2（ヒト上皮成長因子受容体2）阻害剤の市場サイジング
- HER2（ヒト上皮成長因子受容体2）阻害剤の市場予測
- HER2（ヒト上皮成長因子受容体2）阻害剤市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Samsung BioLogicsA Co. Ltd., Amgen Inc., AryoGen Pharmed, AstraZeneca Plc, Biocon Ltd.、Boehringer Ingelheim International GmbH、Bristol Myers Squibb Co.、Celltrion Healthcare Co.Ltd.、Dr. Reddys Laboratories Ltd.、F. Hoffmann La Roche Ltd.、Intas Pharmaceuticals Ltd.、JSC BIOCAD、Merck KGaA、Novartis AG、Pfizer Inc、Puma Biotechnology Inc、 Shanghai Henlius Biotech Inc、 Teva Pharmaceutical Industries Ltd. および Viatris Inc.であり、これらの会社は、いずれも、HER2(ヒト乳酸菌)およびHER2(ヒト乳酸菌)の研究開発に従事しています。また、HER2（ヒト上皮成長因子受容体2）阻害剤市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/her2-human-epidermal-growth-factor-receptor-2-inhibitors-market-size-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Monotherapy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Monotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Monotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Monotherapy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Monotherapy - Year-over-year growth 2021-2026 (%)
o 5.4 Combination therapy - Market size and forecast 2021-2026
o Exhibit 32: Chart on Combination therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Combination therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Combination therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Combination therapy - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 85: Amgen Inc. - Overview
o Exhibit 86: Amgen Inc. - Product / Service
o Exhibit 87: Amgen Inc. - Key offerings
o 10.4 AryoGen Pharmed
o Exhibit 88: AryoGen Pharmed - Overview
o Exhibit 89: AryoGen Pharmed - Product / Service
o Exhibit 90: AryoGen Pharmed - Key offerings
o 10.5 Biocon Ltd.
o Exhibit 91: Biocon Ltd. - Overview
o Exhibit 92: Biocon Ltd. - Business segments
o Exhibit 93: Biocon Ltd. - Key offerings
o Exhibit 94: Biocon Ltd. - Segment focus
o 10.6 Celltrion Healthcare Co. Ltd.
o Exhibit 95: Celltrion Healthcare Co. Ltd. - Overview
o Exhibit 96: Celltrion Healthcare Co. Ltd. - Product / Service
o Exhibit 97: Celltrion Healthcare Co. Ltd. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 98: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 99: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 100: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 101: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 102: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Merck KGaA
o Exhibit 103: Merck KGaA - Overview
o Exhibit 104: Merck KGaA - Business segments
o Exhibit 105: Merck KGaA - Key news
o Exhibit 106: Merck KGaA - Key offerings
o Exhibit 107: Merck KGaA - Segment focus
o 10.9 Novartis AG
o Exhibit 108: Novartis AG - Overview
o Exhibit 109: Novartis AG - Business segments
o Exhibit 110: Novartis AG - Key offerings
o Exhibit 111: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 112: Pfizer Inc. - Overview
o Exhibit 113: Pfizer Inc. - Product / Service
o Exhibit 114: Pfizer Inc. - Key news
o Exhibit 115: Pfizer Inc. - Key offerings
o 10.11 Puma Biotechnology Inc.
o Exhibit 116: Puma Biotechnology Inc. - Overview
o Exhibit 117: Puma Biotechnology Inc. - Business segments
o Exhibit 118: Puma Biotechnology Inc. - Key news
o Exhibit 119: Puma Biotechnology Inc. - Key offerings
o Exhibit 120: Puma Biotechnology Inc. - Segment focus
o 10.12 Viatris Inc.
o Exhibit 121: Viatris Inc. - Overview
o Exhibit 122: Viatris Inc. - Business segments
o Exhibit 123: Viatris Inc. - Key offerings
o Exhibit 124: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 125: Inclusions checklist
o Exhibit 126: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 127: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 128: Research methodology
o Exhibit 129: Validation techniques employed for market sizing
o Exhibit 130: Information sources
o 11.5 List of abbreviations
o Exhibit 131: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Monotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Monotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Monotherapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Monotherapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Combination therapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Combination therapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Combination therapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Combination therapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: AryoGen Pharmed - Overview
Exhibits89: AryoGen Pharmed - Product / Service
Exhibits90: AryoGen Pharmed - Key offerings
Exhibits91: Biocon Ltd. - Overview
Exhibits92: Biocon Ltd. - Business segments
Exhibits93: Biocon Ltd. - Key offerings
Exhibits94: Biocon Ltd. - Segment focus
Exhibits95: Celltrion Healthcare Co. Ltd. - Overview
Exhibits96: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibits97: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits98: F. Hoffmann La Roche Ltd. - Overview
Exhibits99: F. Hoffmann La Roche Ltd. - Business segments
Exhibits100: F. Hoffmann La Roche Ltd. - Key news
Exhibits101: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits103: Merck KGaA - Overview
Exhibits104: Merck KGaA - Business segments
Exhibits105: Merck KGaA - Key news
Exhibits106: Merck KGaA - Key offerings
Exhibits107: Merck KGaA - Segment focus
Exhibits108: Novartis AG - Overview
Exhibits109: Novartis AG - Business segments
Exhibits110: Novartis AG - Key offerings
Exhibits111: Novartis AG - Segment focus
Exhibits112: Pfizer Inc. - Overview
Exhibits113: Pfizer Inc. - Product / Service
Exhibits114: Pfizer Inc. - Key news
Exhibits115: Pfizer Inc. - Key offerings
Exhibits116: Puma Biotechnology Inc. - Overview
Exhibits117: Puma Biotechnology Inc. - Business segments
Exhibits118: Puma Biotechnology Inc. - Key news
Exhibits119: Puma Biotechnology Inc. - Key offerings
Exhibits120: Puma Biotechnology Inc. - Segment focus
Exhibits121: Viatris Inc. - Overview
Exhibits122: Viatris Inc. - Business segments
Exhibits123: Viatris Inc. - Key offerings
Exhibits124: Viatris Inc. - Segment focus
Exhibits125: Inclusions checklist
Exhibits126: Exclusions checklist
Exhibits127: Currency conversion rates for US$
Exhibits128: Research methodology
Exhibits129: Validation techniques employed for market sizing
Exhibits130: Information sources
Exhibits131: List of abbreviations